技术指标
指标
数值
方向
MACD(12,26,9)
-0.650
卖出
RSI(14)
38.476
中性
STOCH(KDJ)(9,3,3)
20.174
卖出
ATR(14)
1.673
低波动
CCI(14)
-107.388
卖出
Williams %R
84.740
超卖
TRIX(12,20)
-0.092
卖出
StochRSI(14)
5.384
超卖
搜索
Polyrizon Ltd
PLRZ添加自选
11.250USD
-0.370-3.18%
收盘 07-31 16:00（美东）报价延迟15分钟
18.09M总市值
亏损市盈率 TTM
关键数据
11.430今开
12.787最高
97.23K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
6.05%换手率
11.620昨收
11.150最低
724.70K成交额
亏损市盈率静
0.86市净率
0.00%股息率 TTM
--ROA
18.20052周最高
1.19量比
-1.60M净利润
1.61M总股本
-4.9017每股收益TTM
--Beta
--ROE
2.88052周最低
14.09%振幅
--毛利率
18.09M总市值
-2.19回报/风险
7.21%风险率
Polyrizon Ltd新闻
即将为您带来更多新闻，敬请期待。。。
技术指标
移动平均线
指标
数值
方向
MA5
11.974
卖出
MA10
13.100
卖出
MA20
13.609
卖出
MA50
13.337
卖出
MA100
13.487
卖出
MA200
11.793
卖出
Polyrizon Ltd简介
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
公司代码PLRZ
公司Polyrizon Ltd
CEOIzraeli (Tomer)
网址https://polyrizon-biotech.com/
公司股东
相关品种
热门品种
常见问题
Polyrizon Ltd(PLRZ)的当前股价是多少？
Polyrizon Ltd(PLRZ)的当前股价是 11.21。
Polyrizon Ltd的股票代码是什么？
Polyrizon Ltd的股票代码是PLRZ。
Polyrizon Ltd股票的52周最高点是多少？
Polyrizon Ltd股票的52周最高点是18.20。
Polyrizon Ltd股票的52周最低点是多少？
Polyrizon Ltd股票的52周最低点是2.88。
Polyrizon Ltd的市值是多少？
Polyrizon Ltd的市值是18.03M。
Polyrizon Ltd(PLRZ)股票的每股收益（EPS TTM）是多少
Polyrizon Ltd(PLRZ)股票的每股收益（EPS TTM）是-4.90。